Maryline Allégra

Université Côte d'Azur — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.7kcitations70works1.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(18), Lung Cancer Treatments and Mutations(16), Melanoma and MAPK Pathways(14), Advanced Breast Cancer Therapies(12), RNA modifications and cancer(9)

Publications70 total

P2.06.88 CfDNA and WBC DNA Sequencing Through MSK-ACCESS Powered With SOPHiA DDM to Delineate Tumor and Clonal Hematopoiesis TP53 Variants in Lung Cancer
Journal of Thoracic Oncology·2025
Detecting actionable mutations from matched plasma-based versus tissue next-generation sequencing in advanced non-small cell lung cancer: a retrospective single centre analysis on site
Journal of Experimental & Clinical Cancer Research·2025· 1 citedOpen Access
Preoperative liquid biopsy for <i>EGFR</i>-mutated detection at diagnostic in early-stage non-small cell lung cancer: real-world experience of a single centre
Journal of Clinical Pathology·2025· 3 cited
EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2024· 3 cited
Comparison and performance of three plasma next-generation sequencing assays versus tissue testing for the detection of actionable driver mutations in advanced non-squamous non-small cell lung carcinoma.
Journal of Clinical Oncology·2024
JoVE Video Dataset
2023
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Journal of Visualized Experiments·2023· 3 cited
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
Cancers·2023· 5 citedOpen Access
Data from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 2 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 5 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Methods and Figure Legends from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 4 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 4 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 2 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 5 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 3 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Methods and Figure Legends from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 1 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
Supplementary Figure 1 from Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Paul Hofman(31), Marius Ilié(28), Véronique Hofman(27), Virginie Tanga(25), Charles‐Hugo Marquette(22), Jonathan Benzaquen(19), Olivier Bordone(18), Robert Ballotti(14), Élodie Long-Mira(14), Simon Heeke(14), Jacques Boutros(14), Corine Bertolotto(12), Philippe Bahadoran(12), Sandra Lassalle(12), Julien Fayada(11), Virginie Lespinet‐Fabre(10), Sylvie Leroy(10), Charlotte Maniel(10), Stéphane Rocchi(8), Christophe Bontoux(8)